
3,3-Dichloro-1-(4-nitrophenyl)-2-piperidinone
Price | Get Latest Price | |
Package | 1kg | 25kg |
Min. Order: | 1kg |
Supply Ability: | 800kg |
Update Time: | 2025-03-28 |
Product Details
Product Name: 3,3-Dichloro-1-(4-nitrophenyl)-2-piperidinone | CAS No.: 881386-01-2 |
Min. Order: 1kg | Purity: 0.99 |
Supply Ability: 800kg | Release date: 2025/03/28 |
Apixaban Intermediate 2 (CAS 881386-01-2) | High-Quality Building Block for Anticoagulant API Synthesis?
?Google Search Keywords?: Apixaban Intermediate 2, CAS 881386-01-2, Anticoagulant API Intermediate, Blood Thinner Synthesis, Factor Xa Inhibitor Precursor
?? ?Product Overview?
Apixaban Intermediate 2 (CAS 881386-01-2) is a vital chemical component in the synthesis of ?Apixaban?, a leading direct oral anticoagulant (DOAC) used to prevent strokes and systemic embolism in patients with atrial fibrillation. This intermediate ensures precise and efficient production of high-purity Apixaban API, adhering to strict pharmaceutical standards.
?Primary Function?: Enables scalable and cost-effective manufacturing of Apixaban API.
?Applications?: Anticoagulant drug production, generic formulations, cardiovascular R&D.
? ?Key Advantages?
? ?Ultra-High Purity?
Purity ≥99% (HPLC/GC validated), ensuring minimal impurities and batch consistency.
?? ?Streamlined Synthesis?
Reduces synthesis steps by 20-30%, improving yield and lowering production costs.
??? ?Controlled Stability?
Stable under inert storage conditions (2-8°C, argon atmosphere), ideal for long-term use.
?? ?Regulatory Alignment?
Compliant with ?ICH Q11? and ?GMP guidelines?, meeting USP/EP specifications.
?? ?Applications?
?API Manufacturing?: Critical precursor in commercial-scale Apixaban production.
?Generic Drug Development?: Supports cost-efficient alternatives to branded anticoagulants.
?Cardiovascular Research?: Used in studies to optimize Factor Xa inhibitor efficacy.
?Quality Control?: Reference standard for impurity profiling and method validation.
?? ?Quality Certifications?
Rigorously tested via ?HPLC, GC, NMR, and Mass Spectrometry? (USP/EP/ICH compliant).
Batch-specific Certificate of Analysis (CoA) with full spectral and chromatographic data.
?? ?Market Trends?
The global anticoagulant market is projected to grow at ?8.2% CAGR (2024-2030)?, fueled by rising cardiovascular disease prevalence and demand for safer DOACs like Apixaban. Intermediate suppliers are pivotal in meeting the surge for generic Apixaban, especially in Asia-Pacific and North American markets.
?? ?Why Choose Us??
?Bulk Scalability?: Production capacity from grams to multi-kilogram batches.
?Custom Synthesis?: Tailored intermediates with modified purity grades or analytical support.
?Global Logistics?: Temperature-controlled shipping with regulatory documentation (SDS, CoA).
Company Profile Introduction
You may like
-
CAS:1029716-44-6
$0.00 / 1kg
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$2.00/1kg |
VIP2Y
|
Jinan Million Pharmaceutical Co., Ltd
|
2023-08-15 | |
$0.00/1kg |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-30 | |
$5.50/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-01-10 | |
$20.00/1KG |
VIP8Y
|
Speranza Chemical Co., Ltd.
|
2019-12-24 | |
$0.00/100KG |
Synbest Biotech(Hangzhou) Co., Ltd
|
2019-11-18 | ||
$0.00/100KG |
Synbest Biotech(Hangzhou) Co., Ltd
|
2019-11-18 | ||
$0.00/100KG |
Synbest Biotech(Hangzhou) Co., Ltd
|
2019-11-18 |
+86-+undefined-+86 13343427080
sales@biocarchem.com